Avenue Therapeutics
BioTech/Drugs - New York, NY, US
Avenue Therapeutics Employees
Avenue Therapeutics Senior Management
Avenue Therapeutics Details
Avenue Therapeutics, Inc. (NASDAQ: ATXI), a Fortress Biotech (NASDAQ: FBIO) Company, is a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol for the management of moderate to moderately severe postoperative pain. IV tramadol may fill a gap in the acute pain market between IV acetaminophen/NSAIDS and IV conventional narcotics. Avenue is currently evaluating IV tramadol in a pivotal Phase 3 program for the management of postoperative pain.
Website:
avenuetx.com
Employees:
10 - 19
HQ:
781-652-4500
Location:
New York, NY, US
Revenue:
1 - 2.5 Million
Avenue Therapeutics Technologies
Email Providers
Outlook
Load Balancers
Nginx
CMS
WordPress.org
Analytics and Tracking
Google Analytics
Other
Mobile Friendly